Assessing Participants' Experiences with Vitiligo from Patient Interviews

Area of Science:

• Dermatology
• Autoimmune Diseases
• Qualitative Research

Background:

• Vitiligo is an autoimmune condition causing skin depigmentation.
• Patients experience significant psychosocial burden and dissatisfaction with current treatments.
• This study explores patient-reported outcomes and expectations for meaningful treatment change.

Purpose of the Study:

• To describe the psychosocial burden of vitiligo.
• To understand patient perspectives on meaningful treatment improvement.
• To identify key goals for vitiligo treatment satisfaction.

Main Methods:

• Qualitative interviews were conducted with vitiligo patients from two clinical trials and a real-world panel.
• Participants discussed disease impact, treatment goals, and satisfaction with facial/body improvement.
• Meaningfulness of change was assessed via patient-reported outcomes and objective measures.

Main Results:

• Reduced self-esteem, social inhibition, and sun sensitivity were major impacts of vitiligo.
• Facial improvement was prioritized over body improvement by most participants.
• Meaningful change was associated with ≥50% facial or ≥25% body repigmentation.

Conclusions:

• Vitiligo patients face substantial psychosocial challenges.
• Repigmentation of both facial and body lesions is crucial for treatment success.
• A minimum of 50% facial and 25% body repigmentation is considered meaningful change.